Trial intelligence / Profile preview

Intrathecal ketamine or midazolam added to bupivacaine for post-cesarean pain

ACTRN12611000729921Phase 2Recruiting

Sponsor
Qazvin University of Medical Sciences
Start
May 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of ketamine, midazolam and bupivacaine, sponsored by Qazvin University of Medical Sciences. Started May 2011; status: recruiting.

02

Drugs

ketaminemidazolambupivacaine

Beyond the preview

Go deeper on ACTRN12611000729921.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12611000729921.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call